Abstract
Biopharmaceuticals represent the fastestgrowing and, in many ways, the most excitingsector within the pharmaceutical industry.Within this Introduction we firstconsider what category of product fallswithin the description of a biopharmaceutical.An overall global snapshot of the currentstatus of the biopharmaceutical sectoris then presented, followed by an overviewof upstream and downstream processingoperations typical of protein-based biopharmaceuticals.General trends in product approvalsare next overviewed and this is followedby a summary of the main actualbiopharmaceutical products that havegained approval to date (within the EUand/or US). These are considered by producttype, the most significant of which areblood-related products, hormones, cytokines,vaccines and monoclonal antibodies.Biopharmaceuticals that have gained approvalfor veterinary application are thenconsidered, and the Introduction concludesby considering some of the innovationsand trends likely to influence theshape of the biopharmaceutical sector in the future.
Original language | English |
---|---|
Title of host publication | Modern Biopharmaceuticals |
Subtitle of host publication | Design, Development and Optimization |
Publisher | Wiley-VCH Verlag GmbH |
Pages | 1-34 |
Number of pages | 34 |
Volume | 1 |
ISBN (Print) | 352731184X, 9783527311842 |
DOIs | |
Publication status | Published - 5 Feb 2008 |
Keywords
- Aquired immunodeficiency syndrome
- Baby hamster kidney
- Erythropoietin
- Eurifel
- Hepatitis B surface antigen